US BROKER MOVES: MA upgraded at BNPP; MU downgraded at Summit Insights

Newsquawk StaffPublished On the live feed at 15 more headlines followed before this page went public
Newsquawk headlinesUTC

PREVIEW: ECB Policy Announcement due Thursday, 19th March at 13:15GMT/09:15EDT

Manager Magazin reports that Bayer's (BAYN GY) chances are increasing that it will land a point victory in the glyphosate war

US BROKER MOVES: MA upgraded at BNPP; MU downgraded at Summit Insights

US Secretary of War Hegseth says US objectives on Iran are on target and on plan; Iranian objectives have not changed from the start; today will again be the largest strike package on Iran; US will finish the operation

[MARKET UPDATE] Crude futures see downticks as US Treasury Secretary Bessent suggests US could do another SPR release to keep price down and that US may unsanction Iranian oil on water

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

UPGRADES

  • Carnival (CCL) Upgraded from Equalweight to Overweight W/ USD 31.00 PT (prev. USD 33.00) at Morgan Stanley
  • Cross Country Healthcare (CCRN) Upgraded from Neutral to Outperform W/ USD 15.00 PT (prev. USD 11.00) at Wedbush
  • Five Below (FIVE) Upgraded from Market Perform to Outperform at William Blair
  • Fluence Energy (FLNC) Upgraded from Sell to Neutral at Guggenheim
  • Kohl’s (KSS) Upgraded from Reduce to Buy W/ USD 20.00 PT at Gordon Haskett
  • Mastercard (MA) Upgraded from Neutral to Outperform W/ USD 600.00 PT at BNP Paribas Exane
  • MoonLake Immunotherapeutics (MLTX) Upgraded from Neutral to Buy W/ USD 40.00 PT (prev. USD 12.00) at Rothschild Redburn
  • Nu Holdings (NU) Upgraded from Neutral to Buy W/ USD 17.60 PT (prev. USD 17.20) at UBS
  • SouthState Corporation (SSB) Upgraded from Market Perform to Outperform at Hovde Group
  • Union Pacific (UNP) Upgraded from In Line to Outperform W/ USD 262.00 PT (prev. USD 260.00) at Evercore ISI

DOWNGRADES

  • CSX (CSX) Downgraded from Outperform to In Line W/ USD 41.00 PT (prev. USD 40.00) at Evercore ISI
  • Freshworks (FRSH) Downgraded from Outperform to Perform at Oppenheimer
  • Kinsale Capital Group (KNSL) Downgraded from Hold to Underperform W/ USD 312.00 PT (prev. USD 392.00) at Jefferies
  • Micron Technology (MU) Downgraded from Buy to Hold at Summit Insights
  • Xponential Fitness (XPOF) Downgraded from Strong Buy to Market Perform at Raymond James

INITIATIONS 

  • Aligos Therapeutics (ALGS) Initiated Buy W/ USD 48.00 PT at Jefferies
  • ALX Oncology (ALXO) Initiated Overweight W/ USD 5.00 PT at Wells Fargo
  • EnerSys (ENS) Initiated Buy W/ USD 190.00 PT at TD Cowen
  • Okta (OKTA) Initiated Outperform W/ USD 100.00 PT at Macquarie
  • Olema Pharmaceuticals (OLMA) Initiated Buy W/ USD 40.00 PT at Jefferies
  • Companhia de Saneamento Básico do Estado de São Paulo (SBS) Initiated Buy W/ USD 36.60 PT at Jefferies
  • Vor Biopharma (VOR) Initiated Overweight W/ USD 30.00 PT at Wells Fargo
Context

The recent upgrades for Mastercard (MA) and several other stocks suggest a bullish sentiment from analysts, particularly at BNP Paribas, indicating growing confidence in MA's growth prospects. Conversely, Micron Technology (MU) being downgraded to Hold denotes heightened caution in the semiconductor sector, which could reflect broader challenges or weakening demand. Monitoring these shifts is crucial as they may influence market sentiment and investor positioning in these sectors.

Related headlines

The whole workspace, free to try.

Try it free